Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
898 Ergebnisse
| GW1K3Y | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,990 % | 0,631 | -0,011 | 3,590 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K4L | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,861 % | 0,637 | -0,010 | 3,138 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K53 | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,992 % | 0,652 | -0,009 | 2,757 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW9CYV | Regeneron Pharmaceuticals Inc./OS/Call [660]/GOLDS | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,448 % | 0,665 | -0,008 | 2,450 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF9RG0 | Regeneron Pharmaceuticals Inc./OS/Call [660]/JPM | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,408 % | 0,608 | -0,015 | 5,370 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH4YHK | Regeneron Pharmaceuticals Inc./OS/Call [660]/JPM | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,587 % | 0,604 | -0,023 | 8,305 | 18.09.2026 | 0,010 | JP Morgan | ||
| JE532F | Regeneron Pharmaceuticals Inc./OS/Call [660]/JPMD | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,298 % | 0,614 | -0,014 | 4,977 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE9GY9 | Regeneron Pharmaceuticals Inc./OS/Call [660]/JPMD | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,036 % | 0,619 | -0,013 | 4,118 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY1K0N | Regeneron Pharmaceuticals Inc./OS/Call [660]/JPMD | - | - | 660,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,455 % | 0,603 | -0,034 | 10,180 | 21.08.2026 | 0,010 | JP Morgan | ||
| GW0VJA | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,599 % | 0,591 | -0,014 | 5,067 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW0VJ2 | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,466 % | 0,601 | -0,012 | 4,337 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VJK | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,379 % | 0,616 | -0,011 | 3,688 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1J4S | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,317 % | 0,637 | -0,009 | 2,899 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K54 | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,436 % | 0,641 | -0,009 | 2,813 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K5C | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,525 % | 0,616 | -0,011 | 3,680 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K91 | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,660 % | 0,625 | -0,010 | 3,188 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW9FC2 | Regeneron Pharmaceuticals Inc./OS/Call [670]/GOLDS | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,746 % | 0,656 | -0,008 | 2,538 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF9RG1 | Regeneron Pharmaceuticals Inc./OS/Call [670]/JPM | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,536 % | 0,585 | -0,015 | 5,492 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH4YJ0 | Regeneron Pharmaceuticals Inc./OS/Call [670]/JPM | - | - | 670,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,970 % | 0,566 | -0,023 | 8,586 | 18.09.2026 | 0,010 | JP Morgan | ||
| JF9RG2 | Regeneron Pharmaceuticals Inc./OS/Call [675]/JPM | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,463 % | 0,574 | -0,015 | 5,568 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH4YHZ | Regeneron Pharmaceuticals Inc./OS/Call [675]/JPM | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,313 % | 0,544 | -0,023 | 8,938 | 18.09.2026 | 0,010 | JP Morgan | ||
| MJ8QU2 |  | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,264 % | 0,575 | -0,016 | 5,231 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KFE | | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,271 % | 0,611 | -0,011 | 3,511 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYU | | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,258 % | 0,548 | -0,026 | 7,923 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN9V79 | | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,204 % | 0,594 | -0,013 | 4,133 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR03TE | | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 47,290 % | 0,638 | -0,010 | 2,678 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MR3CF0 | | Regeneron Pharmaceuticals Inc./OS/Call [675]/MS | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 52,906 % | 0,669 | -0,009 | 2,186 | 16.06.2028 | 0,010 | Morgan Stanley | |
| VY42CM | | Regeneron Pharmaceuticals Inc./OS/Call [675]/VONT | - | - | 675,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,766 % | 0,520 | -0,035 | 10,931 | 21.08.2026 | 0,010 | Vontobel | |
| GW0VJ3 | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,992 % | 0,582 | -0,012 | 4,470 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VJ5 | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,831 % | 0,571 | -0,015 | 5,039 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW0VJL | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,433 % | 0,601 | -0,011 | 3,744 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1J0C | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,180 % | 0,625 | -0,009 | 2,938 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K3X | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,379 % | 0,601 | -0,011 | 3,747 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K4H | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,550 % | 0,612 | -0,010 | 3,235 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K51 | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,399 % | 0,630 | -0,009 | 2,846 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW3SC4 | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,463 % | 0,636 | -0,008 | 2,729 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW9CYU | Regeneron Pharmaceuticals Inc./OS/Call [680]/GOLDS | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,238 % | 0,648 | -0,008 | 2,539 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF9RG3 | Regeneron Pharmaceuticals Inc./OS/Call [680]/JPM | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,915 % | 0,560 | -0,015 | 5,718 | 18.12.2026 | 0,010 | JP Morgan | ||
| JH4YH7 | Regeneron Pharmaceuticals Inc./OS/Call [680]/JPM | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,349 % | 0,524 | -0,023 | 9,122 | 18.09.2026 | 0,010 | JP Morgan | ||
| JE532J | Regeneron Pharmaceuticals Inc./OS/Call [680]/JPMD | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,897 % | 0,569 | -0,014 | 5,267 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE9GYA | Regeneron Pharmaceuticals Inc./OS/Call [680]/JPMD | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,543 % | 0,584 | -0,013 | 4,318 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY1K0M | Regeneron Pharmaceuticals Inc./OS/Call [680]/JPMD | - | - | 680,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,127 % | 0,504 | -0,035 | 11,457 | 21.08.2026 | 0,010 | JP Morgan | ||
| GW0VJB | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,503 % | 0,551 | -0,015 | 5,181 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW0VJP | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,882 % | 0,563 | -0,012 | 4,566 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VJR | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,379 % | 0,585 | -0,011 | 3,807 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1J62 | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,970 % | 0,614 | -0,009 | 2,981 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K3W | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,324 % | 0,586 | -0,011 | 3,810 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K4E | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,404 % | 0,600 | -0,010 | 3,285 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4Y | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,125 % | 0,620 | -0,009 | 2,889 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW3SC8 | Regeneron Pharmaceuticals Inc./OS/Call [690]/GOLDS | - | - | 690,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,171 % | 0,626 | -0,008 | 2,769 | 17.03.2028 | 0,010 | Goldman Sachs |